Kathy Leung1, Marc Lipsitch2, Kwok Yung Yuen3, Joseph T Wu4. 1. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. 2. Department of Epidemiology, Centre for Communicable Disease Dynamics, Harvard TH Chan School of Public Health, Boston, MA, USA. 3. Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China. 4. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Electronic address: joewu@hku.hk.
Abstract
BACKGROUND: Antivirals (eg, oseltamivir) are important for mitigating influenza epidemics. In 2007, an oseltamivir-resistant influenza seasonal A H1N1 strain emerged and spread to global fixation within 1 year. This event showed that antiviral-resistant (AVR) strains can be intrinsically more transmissible than their contemporaneous antiviral-sensitive (AVS) counterpart. Surveillance of AVR fitness is therefore essential. Our objective was to develop a simple method for estimating AVR fitness from surveillance data. METHODS: We defined the fitness of AVR strains as their reproductive number relative to their co-circulating AVS counterparts. We developed a simple method for real-time estimation of AVR fitness from surveillance data. This method requires only information on generation time without other specific details regarding transmission dynamics. We first used simulations to validate this method by showing that it yields unbiased and robust fitness estimates in most epidemic scenarios. We then applied this method to two retrospective case studies and one hypothetical case study. FINDINGS: We estimated that the oseltamivir-resistant A H1N1 strain that emerged in 2007 was 4% (95% credible interval [CrI] 3-5) more transmissible than its oseltamivir-sensitive predecessor and the oseltamivir-resistant pandemic A H1N1 strain that emerged and circulated in Japan during 2013-14 was 24% (95% CrI 17-30) less transmissible than its oseltamivir-sensitive counterpart. We show that in the event of large-scale antiviral interventions during a pandemic with co-circulation of AVS and AVR strains, our method can be used to inform optimal use of antivirals by monitoring intrinsic AVR fitness and drug pressure on the AVS strain. INTERPRETATION: We developed a simple method that can be easily integrated into contemporary influenza surveillance systems to provide reliable estimates of AVR fitness in real time. FUNDING: Research Fund for the Control of Infectious Disease (09080792) and a commissioned grant from the Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region, Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant number U54 GM088558), Area of Excellence Scheme of the Hong Kong University Grants Committee (grant number AoE/M-12/06).
BACKGROUND: Antivirals (eg, oseltamivir) are important for mitigating influenza epidemics. In 2007, an oseltamivir-resistant influenza seasonal A H1N1 strain emerged and spread to global fixation within 1 year. This event showed that antiviral-resistant (AVR) strains can be intrinsically more transmissible than their contemporaneous antiviral-sensitive (AVS) counterpart. Surveillance of AVR fitness is therefore essential. Our objective was to develop a simple method for estimating AVR fitness from surveillance data. METHODS: We defined the fitness of AVR strains as their reproductive number relative to their co-circulating AVS counterparts. We developed a simple method for real-time estimation of AVR fitness from surveillance data. This method requires only information on generation time without other specific details regarding transmission dynamics. We first used simulations to validate this method by showing that it yields unbiased and robust fitness estimates in most epidemic scenarios. We then applied this method to two retrospective case studies and one hypothetical case study. FINDINGS: We estimated that the oseltamivir-resistant A H1N1 strain that emerged in 2007 was 4% (95% credible interval [CrI] 3-5) more transmissible than its oseltamivir-sensitive predecessor and the oseltamivir-resistant pandemic A H1N1 strain that emerged and circulated in Japan during 2013-14 was 24% (95% CrI 17-30) less transmissible than its oseltamivir-sensitive counterpart. We show that in the event of large-scale antiviral interventions during a pandemic with co-circulation of AVS and AVR strains, our method can be used to inform optimal use of antivirals by monitoring intrinsic AVR fitness and drug pressure on the AVS strain. INTERPRETATION: We developed a simple method that can be easily integrated into contemporary influenza surveillance systems to provide reliable estimates of AVR fitness in real time. FUNDING: Research Fund for the Control of Infectious Disease (09080792) and a commissioned grant from the Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region, Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant number U54 GM088558), Area of Excellence Scheme of the Hong Kong University Grants Committee (grant number AoE/M-12/06).
Authors: M Elizabeth Halloran; Frederick G Hayden; Yang Yang; Ira M Longini; Arnold S Monto Journal: Am J Epidemiol Date: 2006-11-06 Impact factor: 4.897
Authors: Murray E Alexander; Christopher S Bowman; Zhilan Feng; Michael Gardam; Seyed M Moghadas; Gergely Röst; Jianhong Wu; Ping Yan Journal: Proc Biol Sci Date: 2007-07-22 Impact factor: 5.349
Authors: Elena A Govorkova; Tatiana Baranovich; Patrick Seiler; Jianling Armstrong; Andrew Burnham; Yi Guan; Malik Peiris; Richard J Webby; Robert G Webster Journal: Antiviral Res Date: 2013-02-28 Impact factor: 5.970
Authors: Sang Woo Park; Benjamin M Bolker; Sebastian Funk; C Jessica E Metcalf; Joshua S Weitz; Bryan T Grenfell; Jonathan Dushoff Journal: J R Soc Interface Date: 2022-06-15 Impact factor: 4.293
Authors: Shi Zhao; Jingzhi Lou; Lirong Cao; Hong Zheng; Marc K C Chong; Zigui Chen; Renee W Y Chan; Benny C Y Zee; Paul K S Chan; Maggie H Wang Journal: BMC Infect Dis Date: 2021-10-07 Impact factor: 3.090
Authors: Haogao Gu; Ruopeng Xie; Dillon C Adam; Joseph L-H Tsui; Daniel K Chu; Lydia D J Chang; Sammi S Y Cheuk; Shreya Gurung; Pavithra Krishnan; Daisy Y M Ng; Gigi Y Z Liu; Carrie K C Wan; Samuel S M Cheng; Kimberly M Edwards; Kathy S M Leung; Joseph T Wu; Dominic N C Tsang; Gabriel M Leung; Benjamin J Cowling; Malik Peiris; Tommy T Y Lam; Vijaykrishna Dhanasekaran; Leo L M Poon Journal: Nat Commun Date: 2022-02-08 Impact factor: 14.919
Authors: Shi Zhao; Salihu S Musa; Marc Kc Chong; Jinjun Ran; Mohammad Javanbakht; Lefei Han; Kai Wang; Nafiu Hussaini; Abdulrazaq G Habib; Maggie H Wang; Daihai He Journal: J Glob Health Date: 2021-12-25 Impact factor: 4.413
Authors: Shi Zhao; Kai Wang; Marc K C Chong; Salihu S Musa; Mu He; Lefei Han; Daihai He; Maggie H Wang Journal: J Theor Biol Date: 2022-03-21 Impact factor: 2.405